Genetic variation in a haplotype block spanningIDE influences Alzheimer disease
- 24 September 2003
- journal article
- research article
- Published by Hindawi Limited in Human Mutation
- Vol. 22 (5) , 363-371
- https://doi.org/10.1002/humu.10282
Abstract
Linkage studies have identified a large (>60‐Mb) region on chromosome 10q that segregates with Alzheimer Disease (AD). Within the region, the gene for insulin degrading enzyme (IDE) represents a notable biological candidate given that it degrades amyloid β‐protein (one of the major constituents of senile plaques) and the intracellular amyloid precursor protein (APP) domain released by γ‐secretase processing. We have used a single nucleotide polymorphism (SNP) genetic association strategy to investigate AD in relation to a 480‐kb region encompassing IDE. A 276‐kb linkage disequilibrium block was revealed that spans three genes (IDE, KNSL1, and HHEX). Assessing this block in several independent sets of case‐control materials (early‐ and late‐onset AD) and focusing also upon quantitative measures that are pertinent to AD diagnosis and severity (MMSE scores, microtubule‐associated protein Tau [MAPT] levels in CSF, degree of brain pathology, and age‐at‐onset) produced extensive evidence for significant AD association. Signals (p‐values ranging from 0.05 to −9) were generally stronger when examining haplotypes rather than individual SNPs, and quantitative trait tests most uniformly revealed the detected associations. Consistent risk alleles and haplotypes were apparent across the study, with effects in some cases as large as that of the ϵ4 allele of APOE. A subsequent mutation screen of exons in all three suspect genes provided no evidence for common causative mutations. These results provide substantial evidence that genetic variation within or extremely close to IDE impacts both disease risk and traits related to the severity of AD. Hum Mutat 22:363–371, 2003.Keywords
This publication has 29 references indexed in Scilit:
- Insulin degrading enzyme (IDE) genetic variants and risk of Alzheimer's disease: evidence of effect modification by apolipoprotein E (APOE)Neuroscience Letters, 2003
- Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivoProceedings of the National Academy of Sciences, 2003
- Polymorphisms of insulin degrading enzyme gene are not associated with Alzheimer's diseaseNeuroscience Letters, 2002
- Confirmation of association between D10S583 and Alzheimer's disease in a case–control sampleNeuroscience Letters, 2002
- Insulin-degrading Enzyme Rapidly Removes the β-Amyloid Precursor Protein Intracellular Domain (AICD)Journal of Biological Chemistry, 2002
- HGVbase: a human sequence variation database emphasizing data quality and a broad spectrum of data sourcesNucleic Acids Research, 2002
- Substantial linkage disequilibrium across the insulin-degrading enzyme locus but no association with late-onset Alzheimer's diseaseHuman Genetics, 2001
- Linkage of Plasma Aβ42 to a Quantitative Locus on Chromosome 10 in Late-Onset Alzheimer's Disease PedigreesScience, 2000
- Evidence for Genetic Linkage of Alzheimer's Disease to Chromosome 10qScience, 2000
- Histopathological criteria for progressive dementia disorders: clinical-pathological correlation and classification by multivariate data analysisActa Neuropathologica, 1987